Validity of some MDS Pharma studies questioned by agency; pending NDAs could be delayed.(Compliance/enforcement): An article from: BioResearch Compliance Report

This digital document is an article from BioResearch Compliance Report, published by Thomson Gale on January 1, 2007. The length of the article is 784 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Validity of some MDS Pharma studies questioned by agency; pending NDAs could be delayed.(Compliance/enforcement)
Author: Joseph Pickett
Publication:BioResearch Compliance Report (Newsletter)
Date: January 1, 2007
Publisher: Thomson Gale
Volume: 7 Issue: 1 Page: 1(3)

Distributed by Thomson Gale